David A. Siegel Immatics N.V. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Immatics N.V. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 100,300 shares of IMTX stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100,300
Previous 157,500
36.32%
Holding current value
$1.14 Million
Previous $1.66 Million
29.61%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding IMTX
# of Institutions
99Shares Held
76.6MCall Options Held
571KPut Options Held
210K-
Rtw Investments, LP New York, NY10MShares$114 Million1.94% of portfolio
-
Wellington Management Group LLP Boston, MA9.54MShares$109 Million0.02% of portfolio
-
Perceptive Advisors LLC New York, NY8.09MShares$92.3 Million2.72% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.43MShares$84.8 Million0.05% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$73.5 Million1.0% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $870M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...